From COVID-19 EUAs to ‘insidious’ remote care risks: ECRI’s top 10 medtech hazards

Risks highlighted by the watchdog include FDA emergency use authorizations and the rapid adoption of telehealth, both of which have increased during the coronavirus pandemic.